-transparent.png){kind=logo}
The results of a prospective, randomized double-blind study of magnesium substitution in pregnancy are reported. Of 997 gravidae, 985 were included in the study. Of these, 485 received magnesium aspartate (Mg 5-Longoral) and 500 a placebo. The results show that the course of pregnancy was better in the group which received the magnesium aspartate in a daily dose of 15 mmol (Mg 5-Longoral) than in the group given placebo. Among the women treated with magnesium were fewer premature births (less than 258 days' gestation). The proportion of newborns, small for date (less than 2500 g), was lower, as was the proportion of newborns with intrauterine retardation (greater than 10th percentile). There were significantly fewer cases of EPH gestosis in the magnesium group, and no serious side effects of treatment. In the authors' opinion, magnesium substitution should be included in routine antenatal care.
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
February 1988,
British journal of obstetrics and gynaecology,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
January 2018,
Journal of pregnancy,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
April 1995,
Journal of cardiothoracic and vascular anesthesia,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
July 1989,
American journal of obstetrics and gynecology,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
January 1998,
The Laryngoscope,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
February 2009,
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
December 1984,
The Australian and New Zealand journal of surgery,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
April 2020,
Obesity surgery,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
January 2016,
Saudi journal of anaesthesia,
L Kovács, and
B G Molnár, and
E Huhn, and
L Bódis
September 2005,
Annals of surgery,
